Skip to main content

Michael Anthony Moody, MD

Associate Professor of Pediatrics
Associate Professor in the Department of Immunology
Member of the Duke Human Vaccine Institute
Campus mail: 2 Genome Ct, MSRB II Room 3007, Durham, NC 27710
Phone: (919) 668-2551
Email address: tony.moody@duke.edu

Tony Moody, MD is an Associate Professor in the Department of Pediatrics, Division of Infectious Diseases and the Department of Immunology at Duke University Medical Center. Research in the Moody lab is focused on understanding the B cell responses during infection, vaccination, and disease. The lab has become a resource for human phenotyping, flow characterization, staining and analysis at the Duke Human Vaccine Institute (DHVI). The Moody lab is currently funded to study influenza, syphilis, HIV-1, and emerging infectious diseases.

Dr. Moody is the director of the Duke CIVICs Vaccine Center (DCVC) at (DHVI) and co-director of the Centers for Research of Emerging Infectious Disease Coordinating Center (CREID-CC). Dr. Moody is co-PI of a U19 program to develop a syphilis vaccine; this program is led by Dr. Justin Radolf at the University of Connecticut. Dr. Moody is also the director of the DHVI Accessioning Unit, a biorepository that provides support for work occurring at DHVI and with its many collaborators around the world by providing processing, shipping, and inventory support for a wide array of projects.

Dr. Moody and his team are involved in many networks studying vaccine response including the Collaborative Influenza Vaccine Innovation Centers (CIVICs), HIV Vaccine Trials Network (HVTN) and the COVID-19 Prevention Network (CoVPN).

Education and Training

  • Fellowship, Pediatric Infectious Diseases, Pediatrics, Duke University, 2003 - 2006
  • Pediatric Chief Resident, Pediatrics, Emory University, 2002 - 2003
  • Pediatric Internship & Residency, Pediatrics, Emory University, 1999 - 2002
  • M.D., Duke University, 1999

Selected Grants and Awards

Publications

LIAO, H. X., M. C. LEVESQUE, K. PATTON, B. BERGAMO, D. JONES, M. A. MOODY, and B. F. HAYNES. “REGULATION OF HUMAN CD44H AND CD44E ISOFORM BINDING TO HYALLURONAN BY PHORBOL-MYRISTATE ACETATE AND ANTI-CD44 MONOCLONAL AND POLYCLONAL ANTIBODIES.” Clinical Research 41, no. 2 (April 1, 1993): A169–A169.

Scholars@Duke

HAYNES, B. F., Y. YASUTOMI, J. V. TORRES, M. B. GARDNER, A. J. LANGLOIS, D. P. BOLOGNESI, T. J. MATTHEWS, et al. “USE OF SYNTHETIC PEPTIDES IN PRIMATES TO INDUCE HIGH-TITERED NEUTRALIZING ANTIBODIES AND MHC CLASS I-RESTRICTED CYTOTOXIC T-CELLS AGAINST AIDS RETROVIRUSES - AN HLA-BASED VACCINE STRATEGY.” Clinical Research 41, no. 2 (April 1, 1993): A261–A261.

Scholars@Duke

Haynes, B. F., Y. Yasutomi, J. V. Torres, M. B. Gardner, A. J. Langlios, D. P. Bolognesi, T. J. Matthews, R. M. Scearce, D. M. Jones, and M. A. Moody. “Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.” Trans Assoc Am Physicians 106 (1993): 33–41.

Scholars@Duke

Seltzman, H. H., M. A. Moody, and M. K. Begum. “Allylic substitution/rearrangement of cannabinoids with trimethylsilyl bromide.” Tetrahedron Letters 33, no. 24 (June 9, 1992): 3443–46. https://doi.org/10.1016/S0040-4039(00)92658-3.

Full Text

ANTHONY, D. C., V. AMARNATH, G. R. SIMONS, M. B. STCLAIR, M. A. MOODY, and D. G. GRAHAM. “ACCUMULATION OF PYRROLE RESIDUES AS THE MOLECULAR-BASIS OF CUMULATIVE NEUROTOXIC DOSE OF 2,5-HEXANEDIONE.” Journal of Neuropathology and Experimental Neurology 47, no. 3 (May 1, 1988): 325–325.

Scholars@Duke

Genter St Clair, M. B., V. Amarnath, M. A. Moody, D. C. Anthony, C. W. Anderson, and D. G. Graham. “Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy.” Chem Res Toxicol 1, no. 3 (May 1988): 179–85. https://doi.org/10.1021/tx00003a009.

Full Text

Pages